{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:25:58Z","timestamp":1784042758392,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128346","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T19:25:36Z","timestamp":1771701936000},"page":"128346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["XBB 1.5 monovalent booster vaccination stimulates oral mucosal and systemic immune responses in healthy adults"],"prefix":"10.1016","volume":"77","author":[{"given":"Nada","family":"Deraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Ragavapuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chom.2024.01.014","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128346_bb0010","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11357-024-01346-2","article-title":"Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents","volume":"47","author":"Abul","year":"2025","journal-title":"Geroscience"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128346_bb0015","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated evidence for Covid-19, RSV, and influenza vaccines for 2025-2026","volume":"393","author":"Scott","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0020","first-page":"285","article-title":"Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines: A systematic review and meta-analysis","volume":"58","author":"Ma","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128346_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","article-title":"SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis","volume":"22","author":"Ssentongo","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128346_bb0030","first-page":"1501","article-title":"Durability of 2024-2025 COVID-19 vaccines against JN.1 subvariants. JAMA","volume":"185","author":"Du","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.vaccine.2026.128346_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128346_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.it.2022.12.007","article-title":"Spiking SARS-CoV-2 antiviral immunity in the respiratory tract","volume":"44","author":"Silva-Sanchez","year":"2023","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128346_bb0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmed.2023.01.003","article-title":"Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines","volume":"29","author":"Fraser","year":"2023","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128346_bb0050","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128346_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820250","article-title":"Natural SARS-CoV-2 infection affects neutralizing activity in saliva of vaccinees","volume":"13","author":"Garziano","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128346_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8051","article-title":"Serum and salivary IgG and IgA response after COVID-19 messenger RNA vaccination","volume":"7","author":"Gorochov","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128346_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104893","article-title":"SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses","volume":"98","author":"Puhach","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128346_bb0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128346_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.20411\/pai.v6i1.441","article-title":"Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva","volume":"6","author":"Ketas","year":"2021","journal-title":"Pathog Immun"},{"key":"10.1016\/j.vaccine.2026.128346_bb0080","doi-asserted-by":"crossref","unstructured":"Declercq, J., S. Gerlo, S. Van Nevel, N. De Ruyck, G. Holtappels, L. Delesie, E. Tobback, I. Lammens, N. Gerebtsov, K. Sedeyn, X. Saelens, B.N. Lambrecht, P. Gevaert, L. Vandekerckhove, and S. Vanhee, Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa. Sci Transl Med, 2024. 16(770): p. eadn2364.","DOI":"10.1126\/scitranslmed.adn2364"},{"issue":"770","key":"10.1016\/j.vaccine.2026.128346_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp8920","article-title":"SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity","volume":"16","author":"Lasrado","year":"2024","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128346_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00102-7","article-title":"Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose","volume":"4","author":"Bladh","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.128346_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127175","article-title":"Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination","volume":"56","author":"Paul","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128346_bb0100","doi-asserted-by":"crossref","unstructured":"Sano, K., D. Bhavsar, G. Singh, D. Floda, K. Srivastava, C. Gleason, P.S. Group, J.M. Carreno, V. Simon, and F. Krammer, SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat Commun, 2022. 13(1): p. 5135.","DOI":"10.1038\/s41467-022-32389-8"},{"key":"10.1016\/j.vaccine.2026.128346_bb0105","doi-asserted-by":"crossref","unstructured":"Woelfel, S., D. Junker, I. Bergamin, P. Meyer-Herbon, R. Stillhard, N. Graf, G. Leinenkugel, J. Dutschler, M. Konig, L. Kammerlander, R. Hauptle, S. Zwyssig, C. Krieger, S. Truniger, S. Koller, K. Metzger-Peter, N. Frei, I. Star Sign Study, W.C. Albrich, M. Friedrich, C. Bernsmeier, J.H. Niess, W. Korte, J.J. Burgi, A. Dulovic, N. Schneiderhan-Marra, D. Semela, and S. Brand, Star light study: XBB.1.5 COVID-19 mRNA vaccines boost systemic but not mucosal immunity against the SARS-CoV-2 JN.1 variant in patients with chronic liver disease. Vaccines (Basel), 2024. 12(11).","DOI":"10.3390\/vaccines12111241"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128346_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1514","article-title":"From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 2019","volume":"13","author":"Jin","year":"2024","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.vaccine.2026.128346_bb0115","doi-asserted-by":"crossref","first-page":"2032057","DOI":"10.1155\/2020\/2032057","article-title":"The effects of secretory IgA in the mucosal immune system","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128346_bb0120","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S1473-3099(23)00421-8","article-title":"Mucosal IgA protects against BQ.1 and BQ.1.1 infection","volume":"23","author":"Marking","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"577","key":"10.1016\/j.vaccine.2026.128346_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128346_bb0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128346_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128346_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro2384","article-title":"The role of secretory antibodies in infection immunity","volume":"8","author":"Strugnell","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"577","key":"10.1016\/j.vaccine.2026.128346_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"issue":"8056","key":"10.1016\/j.vaccine.2026.128346_bb0150","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41586-024-08511-9","article-title":"Differential protection against SARS-CoV-2 reinfection pre- and post-omicron","volume":"639","author":"Chemaitelly","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128346_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/clinchem\/hvad169","article-title":"Clinical assessment of SARS-CoV-2 antibodies in Oral fluids following infection and vaccination","volume":"70","author":"Heaney","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/j.vaccine.2026.128346_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112583","article-title":"The role of immunoglobulin transport receptor, neonatal fc receptor in mucosal infection and immunity and therapeutic intervention","volume":"138","author":"Qian","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2026.128346_bb0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an Iron-binding protein that can help defend against viruses and Bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128346_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103856","article-title":"HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: strategy to combat COVID-19","volume":"25","author":"Zhang","year":"2022","journal-title":"iScience"},{"issue":"7809","key":"10.1016\/j.vaccine.2026.128346_bb0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128346_bb0190","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/cid\/ciab447","article-title":"Reduced BNT162b2 messenger RNA vaccine response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-naive nursing home residents","volume":"73","author":"Canaday","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128346_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15585\/mmwr.mm7204a4","article-title":"SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and omicron BA.1 and BA.4\/BA.5 variants in nursing home residents after receipt of bivalent COVID-19 vaccine - Ohio and Rhode Island, September-November 2022","volume":"72","author":"Canaday","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128346_bb0200","doi-asserted-by":"crossref","unstructured":"Garcia-Beltran, W.F., K.J. St Denis, A. Hoelzemer, E.C. Lam, A.D. Nitido, M.L. Sheehan, C. Berrios, O. Ofoman, C.C. Chang, B.M. Hauser, J. Feldman, A.L. Roederer, D.J. Gregory, M.C. Poznansky, A.G. Schmidt, A.J. Iafrate, V. Naranbhai, and A.B. Balazs, mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 omicron variant. Cell, 2022. 185(3): p. 457\u2013466 e4.","DOI":"10.1016\/j.cell.2021.12.033"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128346_bb0205","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1172\/JCI141206","article-title":"Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization","volume":"130","author":"Salazar","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2026.128346_bb0210","article-title":"Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals","volume":"11","author":"Butler","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128346_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128346_bb0220","doi-asserted-by":"crossref","first-page":"1346749","DOI":"10.3389\/fimmu.2024.1346749","article-title":"Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum","volume":"15","author":"Bladh","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128346_bb0225","article-title":"Systemic and mucosal immunogenicity of monovalent XBB.1.5-adapted COVID-19 mRNA vaccines in patients with inflammatory bowel disease","volume":"12","author":"Woelfel","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128346_bb0230","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/vaccines11111644","article-title":"Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection","volume":"11","author":"Sobhani","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128346_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00989-21","article-title":"Anti-SARS-CoV-2 antibody levels measured by the AdviseDx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity","volume":"59","author":"Bradley","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128346_bb0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2021.10.004","article-title":"Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen","volume":"240","author":"Dobano","year":"2022","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128346_bb0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj2710285","article-title":"The structure and function of human IgA","volume":"271","author":"Kerr","year":"1990","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128346_bb0255","article-title":"Percentage of asymptomatic infections among SARS-CoV-2 omicron variant-positive individuals: A systematic review and Meta-analysis","volume":"10","author":"Shang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128346_bb0260","doi-asserted-by":"crossref","first-page":"1330864","DOI":"10.3389\/fimmu.2024.1330864","article-title":"Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva","volume":"15","author":"Winklmeier","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128346_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2025.111223","article-title":"Expression of SARS-CoV-2 spike protein in cerebral arteries: implications for hemorrhagic stroke post-mRNA vaccination","volume":"136","author":"Ota","year":"2025","journal-title":"J Clin Neurosci"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128346_bb0270","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128346_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1218","article-title":"Long-lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID-19 vaccination","volume":"12","author":"Boros","year":"2024","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128346_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol Biomed"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128346_bb0285","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(22)00834-9","article-title":"7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection","volume":"23","author":"Marking","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128346_bb0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1473-3099(22)00595-3","article-title":"Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark","volume":"23","author":"Hansen","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128346_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105912","article-title":"Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection","volume":"120","author":"Marking","year":"2025","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128346_bb0300","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","article-title":"The dispersal of mucosal memory B cells: evidence from persistent EBV infection","volume":"16","author":"Laichalk","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128346_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127356","article-title":"A review of currently licensed mucosal COVID-19 vaccines","volume":"61","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128346_bb0310","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v5i0.20401","article-title":"Secretory immunity with special reference to the oral cavity","volume":"5","author":"Brandtzaeg","year":"2013","journal-title":"J Oral Microbiol"},{"key":"10.1016\/j.vaccine.2026.128346_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104435","article-title":"Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine","volume":"88","author":"Azzi","year":"2023","journal-title":"EBioMedicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:59:49Z","timestamp":1779076789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"alternative-id":["S0264410X26001544"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128346","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"XBB 1.5 monovalent booster vaccination stimulates oral mucosal and systemic immune responses in healthy adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128346"}}